Hasan Karakuş
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hasan Karakuş has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Tuğrul Hoşbul
Department of Medical Microbiology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Türkiye
2 shared publications - Abdirahim Ali Adam1 shared publication
- Baris Otlu
Department of Medical Microbiology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye
1 shared publication - Elif Seren Tanrıverdi
Department of Medical Microbiology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye
1 shared publication - Fatih Şahiner
Division of Medical Virology, Department of Medical Microbiology, Gulhane Military Medical Academy, Ankara, Turkey
1 shared publication - Gokce Cicek Karaman
Clinic of Medical Microbiology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 5 July 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 1-7
Evaluation of colistin susceptibility by four phenotypic methods compared to broth microdilution in multidrug-resistant Klebsiella pneumoniae
Colistin, one of the last-line treatment options for carbapenem-resistant microorganisms, presents challenges in determining its antimicrobial susceptibility. This study aims to compare colistin broth disk elution (CBDE), modified CBDE (mCBDE), the colistin agar test (CAT), and rapid polymyxin NP (RPNP) tests with the reference broth microdilution (BMD) in determining colistin susceptibility of 116 multidrug-resistant (MDR) Klebsiella pneumoniae isolates. Isolates were collected from blood and respiratory tract samples of different patients between 2022 and 2023 in Türkiye. For each isolate, a single 0.5 McFarland inoculum was prepared to inoculate CBDE, mCBDE, and CAT in parallel, then the suspension was adjusted to a density of 3-3.5 for RPNP. All tests were conducted simultaneously under the same incubation conditions. In the comparative analysis of the tests, bias, essential agreement (EA), and sensitivity were assessed according to ISO 20776-2:2021. Additionally, EA, categorical agreement (CA), major error (ME), and very major error (VME) were evaluated by the CLSI guidelines. The minimum inhibitory concentration (MIC) values for MIC50 and MIC90 were 2 µg/ml and 16 µg/ml, respectively. All methods achieved the CA above 90%, with no VMEs (0%). The ME rates for CBDE, mCBDE, CAT, and RPNP were 3.4%, 8.6%, 12%, and 10.3%, respectively. The EA rates of CBDE and CAT were 95.6% and 91.3%, respectively, while bias rates were 10.8% and 24.7%. The sensitivity of both mCBDE and RPNP was 100%. Consistent with other studies in this field, a comprehensive evaluation of all methods revealed that 58.3% (7/12) of the isolates responsible for MEs had an MIC value of 1 µg/ml, 25% (3/12) had an MIC of 2 µg/ml, and 16.6% (2/12) had an MIC of 0.25 µg/ml. Most errors occurred in isolates with MIC values near the breakpoint. The CBDE demonstrated the best performance in all criteria assessed. This study highlights the benefits of alternative phenotypic methods compared to reference BMD for assessing colistin susceptibility, including ease of use, cost-effectiveness, and rapid results. Our findings emphasize the need for more comprehensive multicenter studies to validate and improve these methods, especially those with more isolates with MIC values near the breakpoint.
- 5 July 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 1-7
Open AccessEvaluation of colistin susceptibility by four phenotypic methods compared to broth microdilution in multidrug-resistant Klebsiella pneumoniae
Colistin, one of the last-line treatment options for carbapenem-resistant microorganisms, presents challenges in determining its antimicrobial susceptibility. This study aims to compare colistin broth disk elution (CBDE), modified CBDE (mCBDE), the colistin agar test (CAT), and rapid polymyxin NP (RPNP) tests with the reference broth microdilution (BMD) in determining colistin susceptibility of 116 multidrug-resistant (MDR) Klebsiella pneumoniae isolates. Isolates were collected from blood and respiratory tract samples of different patients between 2022 and 2023 in Türkiye. For each isolate, a single 0.5 McFarland inoculum was prepared to inoculate CBDE, mCBDE, and CAT in parallel, then the suspension was adjusted to a density of 3-3.5 for RPNP. All tests were conducted simultaneously under the same incubation conditions. In the comparative analysis of the tests, bias, essential agreement (EA), and sensitivity were assessed according to ISO 20776-2:2021. Additionally, EA, categorical agreement (CA), major error (ME), and very major error (VME) were evaluated by the CLSI guidelines. The minimum inhibitory concentration (MIC) values for MIC50 and MIC90 were 2 µg/ml and 16 µg/ml, respectively. All methods achieved the CA above 90%, with no VMEs (0%). The ME rates for CBDE, mCBDE, CAT, and RPNP were 3.4%, 8.6%, 12%, and 10.3%, respectively. The EA rates of CBDE and CAT were 95.6% and 91.3%, respectively, while bias rates were 10.8% and 24.7%. The sensitivity of both mCBDE and RPNP was 100%. Consistent with other studies in this field, a comprehensive evaluation of all methods revealed that 58.3% (7/12) of the isolates responsible for MEs had an MIC value of 1 µg/ml, 25% (3/12) had an MIC of 2 µg/ml, and 16.6% (2/12) had an MIC of 0.25 µg/ml. Most errors occurred in isolates with MIC values near the breakpoint. The CBDE demonstrated the best performance in all criteria assessed. This study highlights the benefits of alternative phenotypic methods compared to reference BMD for assessing colistin susceptibility, including ease of use, cost-effectiveness, and rapid results. Our findings emphasize the need for more comprehensive multicenter studies to validate and improve these methods, especially those with more isolates with MIC values near the breakpoint.
- 30 October 2024
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 58 (4) , 393-407
Klinik Pseudomonas aeruginosa İzolatlarının Antibiyotik Direncinde Resistance Nodulation Division (RND) Dışa Atım Pompası ve OPRD Ekspresyon Düzeylerinin Araştırılması
The increasing antibiotic resistance in Pseudomonas aeruginosa, responsible for both community-acquired and hospital-acquired infections, is of global significance. The primary mechanisms contributing to resistance development in P.aeruginosa include the increased activity of efflux pumps, decreased permeability of outer membrane porins and the production of carbapenemases. This study aimed to determine the effects of resistance nodulation division (RND) efflux pumps, outer membrane porin D (OprD) outer membrane protein and carbapenemase production on the development of resistance to different antibiotics in P.aeruginosa isolates. Eighty P.aeruginosa isolates obtained from clinical samples in our hospital between 2019 and 2021 were included in the study. Species-level identification of the isolates was performed using MALDI-TOF MS (Bruker Daltonics, Germany). Antibiotic susceptibilities were determined using the VITEK (R) 2 (bioM & eacute;rieux, France) system according to the criteria of the European Committee on Antimicrobial Susceptibility Testing (EUCAST). The expression levels of the outer membrane porin protein OprD and the regulatory genes of efflux pumps (mexB, mex C, mex E, and mex X ) were investigated using real-time quantitative reverse transcriptase polymerase chain reaction (Rt-qPCR). The rpsL gene was used as the reference gene and P.aeruginosa PAO1 strain was used as the control strain in Rt-qPCR. Comparative expression analysis was calculated using the delta-delta cycle threshold (Delta Delta Ct) method. The presence of bla(OXA-48), bla(NDM), bla(VIM), bla(IMP), bla(KPC) and bla(OXA-10) was investigated by PCR. Clonal relationships among the isolates were determined by AP-PCR using the M13 primer. Band profiles were analyzed using GelCompar II (Applied Maths) software. Decreased OprD expression was detected in 63.7% of the isolates and 74% of carbapenem-resistant isolates. The decrease in OprD expression was found to be significant only between the carbapenem-susceptible (n= 30) and carbapenem-resistant (n= 50) groups (p= 0.014). The overexpression rate of mexB was 82% in carbapenem-resistant isolates and 33% in carbapenem-susceptible isolates; 76.6% in multidrug-resistant (MDR) isolates and 45.5% in non-MDR isolates (p= 0.001 and p= 0.004, respectively). The overexpression rate of mexX was 68% and 40% in the amikacin-resistant and susceptible groups, respectively; and 64.3% and 40.4% in the gentamicin-resistant and susceptible groups, respectively (p= 0.02 and p= 0.041, respectively). Over- expression of mexX was found in 61.7% of MDR isolates and 30.3% of non-MDR isolates (p= 0.006). No significant difference was found in the expression of mexC and mexE between antibiotic-susceptible and resistant groups. While bla OXA-10 was detected in 32% (16/50) of carbapenem-resistant isolates, bla OXA-48 , bla NDM , bla VIM , bla IMP , bla KPC were not detected in any of the isolates. AP-PCR analysis identified 64 different genotypes and no dominant genotype was observed. The isolates were grouped into 14 different clusters with a clustering rate of 36%. RND efflux systems play a crucial role in the development of antibiotic resistance in P.aeruginosa. This study showed that overexpression of mexB and decreased expression of OprD contributed to the development of carbapenem resistance, while overexpression of mexX contributed to the development of amikacin and gentamicin resistance. Overexpression of mexB and mexX has significant correlation with MDR isolates. The detection of bla OXA-10 in 16 isolates suggests that the presence of this resistance gene may contribute to the development of carbapenem resistance.
- 30 October 2024
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 58 (4) , 393-407
Klinik Pseudomonas aeruginosa İzolatlarının Antibiyotik Direncinde Resistance Nodulation Division (RND) Dışa Atım Pompası ve OPRD Ekspresyon Düzeylerinin Araştırılması
The increasing antibiotic resistance in Pseudomonas aeruginosa, responsible for both community-acquired and hospital-acquired infections, is of global significance. The primary mechanisms contributing to resistance development in P.aeruginosa include the increased activity of efflux pumps, decreased permeability of outer membrane porins and the production of carbapenemases. This study aimed to determine the effects of resistance nodulation division (RND) efflux pumps, outer membrane porin D (OprD) outer membrane protein and carbapenemase production on the development of resistance to different antibiotics in P.aeruginosa isolates. Eighty P.aeruginosa isolates obtained from clinical samples in our hospital between 2019 and 2021 were included in the study. Species-level identification of the isolates was performed using MALDI-TOF MS (Bruker Daltonics, Germany). Antibiotic susceptibilities were determined using the VITEK (R) 2 (bioM & eacute;rieux, France) system according to the criteria of the European Committee on Antimicrobial Susceptibility Testing (EUCAST). The expression levels of the outer membrane porin protein OprD and the regulatory genes of efflux pumps (mexB, mex C, mex E, and mex X ) were investigated using real-time quantitative reverse transcriptase polymerase chain reaction (Rt-qPCR). The rpsL gene was used as the reference gene and P.aeruginosa PAO1 strain was used as the control strain in Rt-qPCR. Comparative expression analysis was calculated using the delta-delta cycle threshold (Delta Delta Ct) method. The presence of bla(OXA-48), bla(NDM), bla(VIM), bla(IMP), bla(KPC) and bla(OXA-10) was investigated by PCR. Clonal relationships among the isolates were determined by AP-PCR using the M13 primer. Band profiles were analyzed using GelCompar II (Applied Maths) software. Decreased OprD expression was detected in 63.7% of the isolates and 74% of carbapenem-resistant isolates. The decrease in OprD expression was found to be significant only between the carbapenem-susceptible (n= 30) and carbapenem-resistant (n= 50) groups (p= 0.014). The overexpression rate of mexB was 82% in carbapenem-resistant isolates and 33% in carbapenem-susceptible isolates; 76.6% in multidrug-resistant (MDR) isolates and 45.5% in non-MDR isolates (p= 0.001 and p= 0.004, respectively). The overexpression rate of mexX was 68% and 40% in the amikacin-resistant and susceptible groups, respectively; and 64.3% and 40.4% in the gentamicin-resistant and susceptible groups, respectively (p= 0.02 and p= 0.041, respectively). Over- expression of mexX was found in 61.7% of MDR isolates and 30.3% of non-MDR isolates (p= 0.006). No significant difference was found in the expression of mexC and mexE between antibiotic-susceptible and resistant groups. While bla OXA-10 was detected in 32% (16/50) of carbapenem-resistant isolates, bla OXA-48 , bla NDM , bla VIM , bla IMP , bla KPC were not detected in any of the isolates. AP-PCR analysis identified 64 different genotypes and no dominant genotype was observed. The isolates were grouped into 14 different clusters with a clustering rate of 36%. RND efflux systems play a crucial role in the development of antibiotic resistance in P.aeruginosa. This study showed that overexpression of mexB and decreased expression of OprD contributed to the development of carbapenem resistance, while overexpression of mexX contributed to the development of amikacin and gentamicin resistance. Overexpression of mexB and mexX has significant correlation with MDR isolates. The detection of bla OXA-10 in 16 isolates suggests that the presence of this resistance gene may contribute to the development of carbapenem resistance.
- 26 July 2023
- Published by Journal of Molecular Virology and Immunology in Journal of Molecular Virology and Immunology
An Example of the Importance of Electronic Health Records from Mogadishu, Somalia: Hepatitis B Prevalence and Co-infections with Hepatitis C
The epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) has been discussed in detail from different aspects around the world. Current epidemiological data has critical importance in the planning and carrying out of public health policies for the prevention of transmission and spread of these infections, and the treatment of chronic infections, and to reduce the burden and mortality associated with complications such as cirrhosis and liver cancer by national health authorities and international health institutions, especially the World Health Organization. Elimination of a social health problem is possible by first raising awareness, then determining the dimensions of the problem, and planning and implementing interventions for a solution. Somalia was in the position of a region where access to diagnosis and treatment for many life-threatening diseases was difficult, aside from the monitoring of public health criteria due to the unstable situations that has continued for more than 40 years. Until recently, basic health parameters and epidemiological predictions in Somalia were monitored through estimates based on data from neighboring countries or on data obtained from small groups from Somalia immigrants settled different parts of the world. However, this situation is changing rapidly. A tertiary education and research hospital established in the capital, Mogadishu, with the coordination of the Türkiye and Somalia governments, and which has become the largest health center in the country today; contributes to understanding the extent of the serious health problems faced by the country by pioneering specialized training and scientific studies, in addition to providing health care. Electronic health records have been kept regularly since 2015 in this hospital, where hundreds of thousands of patients receive treatment or undergo health checks every year and it has been the source of numerous retrospective epidemiological studies some of which have exceeded 100 thousand cases, in different age groups and sub-populations. These studies include human immunodeficiency virus (HIV) prevalence and complications, HCV prevalence and genotype distribution, prevalence and epidemiology of parasitic infections, incidence of tuberculosis and related complications, cancer incidence and distribution, causes of blindness, thyroid diseases, antibiotic resistance profiles, and the epidemiology of various organ-specific diseases. Dozens of studies using the hospital records were included in the scientific literature between 2020 and 2023. In this study, a four-year period between November 2015 and November 2019, HBV serological test results of more than 100,000 different patients are presented. HBsAg and anti-HBs seropositivity for all age groups was found to be 8.1% (9,405/115,946) and 32.7% (25,988/79,410), respectively. When the anti-HCV test results of HBsAg positive patients were examined, the rate of HCV co-infections was found to be 0.9% (82/9,405). HBsAg and anti-HBs seropositivity were significantly higher in males than females (p<0.001). HBV, HCV, and co-infection incidence tended to decrease. Conversely, vaccination rates (especially in children under one year of age) tended to increase. While the comprehensive data presented in this study provide us with important and new information about the prevalence and co-infection rates of viral hepatitis in the country, many topics including HBV genotypes, hepatitis D frequency, access to treatment rates, complication rates, and HBV vaccination rates are still waiting to be researched in Somalia. In the region where it is not possible to carry out field studies, epidemiological data provided by electronic health records have become a country's window to the world.
- 26 July 2023
- Published by Journal of Molecular Virology and Immunology in Journal of Molecular Virology and Immunology
An Example of the Importance of Electronic Health Records from Mogadishu, Somalia: Hepatitis B Prevalence and Co-infections with Hepatitis C
The epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) has been discussed in detail from different aspects around the world. Current epidemiological data has critical importance in the planning and carrying out of public health policies for the prevention of transmission and spread of these infections, and the treatment of chronic infections, and to reduce the burden and mortality associated with complications such as cirrhosis and liver cancer by national health authorities and international health institutions, especially the World Health Organization. Elimination of a social health problem is possible by first raising awareness, then determining the dimensions of the problem, and planning and implementing interventions for a solution. Somalia was in the position of a region where access to diagnosis and treatment for many life-threatening diseases was difficult, aside from the monitoring of public health criteria due to the unstable situations that has continued for more than 40 years. Until recently, basic health parameters and epidemiological predictions in Somalia were monitored through estimates based on data from neighboring countries or on data obtained from small groups from Somalia immigrants settled different parts of the world. However, this situation is changing rapidly. A tertiary education and research hospital established in the capital, Mogadishu, with the coordination of the Türkiye and Somalia governments, and which has become the largest health center in the country today; contributes to understanding the extent of the serious health problems faced by the country by pioneering specialized training and scientific studies, in addition to providing health care. Electronic health records have been kept regularly since 2015 in this hospital, where hundreds of thousands of patients receive treatment or undergo health checks every year and it has been the source of numerous retrospective epidemiological studies some of which have exceeded 100 thousand cases, in different age groups and sub-populations. These studies include human immunodeficiency virus (HIV) prevalence and complications, HCV prevalence and genotype distribution, prevalence and epidemiology of parasitic infections, incidence of tuberculosis and related complications, cancer incidence and distribution, causes of blindness, thyroid diseases, antibiotic resistance profiles, and the epidemiology of various organ-specific diseases. Dozens of studies using the hospital records were included in the scientific literature between 2020 and 2023. In this study, a four-year period between November 2015 and November 2019, HBV serological test results of more than 100,000 different patients are presented. HBsAg and anti-HBs seropositivity for all age groups was found to be 8.1% (9,405/115,946) and 32.7% (25,988/79,410), respectively. When the anti-HCV test results of HBsAg positive patients were examined, the rate of HCV co-infections was found to be 0.9% (82/9,405). HBsAg and anti-HBs seropositivity were significantly higher in males than females (p<0.001). HBV, HCV, and co-infection incidence tended to decrease. Conversely, vaccination rates (especially in children under one year of age) tended to increase. While the comprehensive data presented in this study provide us with important and new information about the prevalence and co-infection rates of viral hepatitis in the country, many topics including HBV genotypes, hepatitis D frequency, access to treatment rates, complication rates, and HBV vaccination rates are still waiting to be researched in Somalia. In the region where it is not possible to carry out field studies, epidemiological data provided by electronic health records have become a country's window to the world.
- 16 July 2023
- Published by Life and Medical Sciences in Life and Medical Sciences
Choosing Wisely in Immunology Laboratory: Reviewing of Antinuclear Antibody (ANA) Test Requests and Results Together with Other Tests
In this study, it was aimed to examine the distribution and positivity rates of the tests reported in the medical immunology laboratory of a tertiary education and research hospital, and to determine the distribution of antinuclear antibody (ANA) test requests, which constitute a significant part of the workload, according to disease diagnosis/preliminary diagnoses and clinical departments, and to examine the possible causes and costs of incorrect-inappropriate test orders, and to consider effective and applicable solution suggestions. In the study, a retrospective review of data on all immunoserology tests (n=94,954 individual parameters) reported approximately over a three-year period starting from September 2016 was presented. When the tests are divided into three main groups; among all test parameters, ANA tests ranked first with a rate of 20.3% (n=19,248). In our study, the positivity rate of ANA tests evaluated by the indirect immunofluorescence antibody (IFA) method was found as 23.1% (n=4,446). The number of reported parameters of specific autoantibody tests (second group), which include many different tests (IFA, ELISA, and immunoblot based), was 67,976, and the overall positivity was 2.96%, varies between 0.8% and 12.7%, depending on the antibody type. In the ELISA-based brucella and antiviral (herpes simplex virus 1 and 2, varicella virus, measles virus, mumps virus, parvovirus B19) IgM and IgG antibody tests in the third group, the highest positivity rate was observed according to the number of tests requested (30.1%, 2,324/7,730). In ANA-positive patients, the most frequently detected ANA-related autoantibodies were anti-dsDNA (9.2%) and anti-SS-A (8.2%). In ANA-negative patients, in simultaneously ordered tests, anti-dsDNA positivity was found to be 3.3%, while positivity rates for other ANA-related specific autoantibodies were in the range of 0.0-0.31%. ANA tests were most frequently ordered from the rheumatology department (34.2%), and also the highest ANA positivity rate (28%) was observed in this unit. The most notable reason for unnecessary test ordering was the test requests by different physicians for the same patient. We consider that evaluation of ANA tests at a dilution of 1:100 may lead to unnecessary second-step testing (specific autoantibodies) due to the low positive results, and that narrow-scope second-step autoantibody test panels will have negative effects on laboratory efficiency.
- 16 July 2023
- Published by Life and Medical Sciences in Life and Medical Sciences
Choosing Wisely in Immunology Laboratory: Reviewing of Antinuclear Antibody (ANA) Test Requests and Results Together with Other Tests
In this study, it was aimed to examine the distribution and positivity rates of the tests reported in the medical immunology laboratory of a tertiary education and research hospital, and to determine the distribution of antinuclear antibody (ANA) test requests, which constitute a significant part of the workload, according to disease diagnosis/preliminary diagnoses and clinical departments, and to examine the possible causes and costs of incorrect-inappropriate test orders, and to consider effective and applicable solution suggestions. In the study, a retrospective review of data on all immunoserology tests (n=94,954 individual parameters) reported approximately over a three-year period starting from September 2016 was presented. When the tests are divided into three main groups; among all test parameters, ANA tests ranked first with a rate of 20.3% (n=19,248). In our study, the positivity rate of ANA tests evaluated by the indirect immunofluorescence antibody (IFA) method was found as 23.1% (n=4,446). The number of reported parameters of specific autoantibody tests (second group), which include many different tests (IFA, ELISA, and immunoblot based), was 67,976, and the overall positivity was 2.96%, varies between 0.8% and 12.7%, depending on the antibody type. In the ELISA-based brucella and antiviral (herpes simplex virus 1 and 2, varicella virus, measles virus, mumps virus, parvovirus B19) IgM and IgG antibody tests in the third group, the highest positivity rate was observed according to the number of tests requested (30.1%, 2,324/7,730). In ANA-positive patients, the most frequently detected ANA-related autoantibodies were anti-dsDNA (9.2%) and anti-SS-A (8.2%). In ANA-negative patients, in simultaneously ordered tests, anti-dsDNA positivity was found to be 3.3%, while positivity rates for other ANA-related specific autoantibodies were in the range of 0.0-0.31%. ANA tests were most frequently ordered from the rheumatology department (34.2%), and also the highest ANA positivity rate (28%) was observed in this unit. The most notable reason for unnecessary test ordering was the test requests by different physicians for the same patient. We consider that evaluation of ANA tests at a dilution of 1:100 may lead to unnecessary second-step testing (specific autoantibodies) due to the low positive results, and that narrow-scope second-step autoantibody test panels will have negative effects on laboratory efficiency.